The coronavirus (COVID-19) is impacting businesses globally by disrupting supply chains, travel, production and consumption, threatening operations and financial markets. Companies are navigating a new reality and facing valuation challenges with respect to developing financial forecasts and projections, cost of capital estimates, reliable market benchmarks and more.
Despite the market fluctuations, companies, alternative asset managers and investors need to determine the fair value of investments in non-traded debt and equity for quarterly reporting, as well as accurately assessing whether the recent stock market declines have created a triggering event necessitating testing of impairment of goodwill, other intangibles and long-lived assets for financial reporting.
In this special edition of Valuation Insights, we address a number of important and timely global valuation and risk management issues from measuring fair value of investments and assessing potential goodwill and other asset impairment, to transfer pricing and supply chain planning and understanding cost of capital considerations in a volatile market.
Be sure to check out our library of CPE-eligible virtual events and webcasts, where our valuation experts discuss issues and topics that may be impacting your business.
We hope that you will find this and future issues of the newsletter informative.
Cost of Capital and Other Valuation Considerations in the Current Environment
by Carla Nunes
Goodwill Impairment in the COVID-19 Environment
by Marianna Todorova
Measuring Fair Value in Times of Significant Uncertainty
by David Larsen
Transfer Pricing and Supply Chain Planning During and After COVID-19
by Douglas Fone
Rethink Your Risk Assessment During COVID-19